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TUMOR IMPRINTS AS A SOURCE OF NUCLEAR SUBSTRATE FOR THE
DETECTION OF ANTINUCLEAR FACTORS*
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AND THOMAS R. NEBLETT, PH.D4
To elucidate further the immunologic signifi-
cance of our recent report of gamma globulin
localization in skin lesions of lupus erythematosus
and various dermatoses (1), we studied the sera of
patients with positive lupus erythematosus cell
tests, scieroderma and various dermatoses for
antibodies to skin components by the indirect
fluorescent technic.
Several scleroderma sera produced small bright
yellow-green fluorescent speckles which appeared
to be in epidermal cell nuclei (Fig. 1). To deter-
mine whether this could represent the "speckled"
nuclear fluorescence described by Beck (2), we
treated various tissues with these scm. We con-
firmed that this was indeed the previously de-
scribed "speckled" nuclear fluorescence and found
that tumor imprints were far superior to prepara-
tions using normal cells as nuclear substrate for
the detection of antinuclear factors.
MATERIALS AND METHODS
Clinical Material
Sera of normal individuals and of patients with
scleroderma, positive lupus erythematosus cell
tests and various dermatoses were investigated.
Sections were cut in a cryostat at —15° C. six
microns thick from quick-frozen surgically re-
moved tumors, liver, kidney, spleen and involved,
uninvolved and normal skin. Touch imprints were
made from 13 different tumors (see Table I) and
from normal tissues which included liver, spleen,
thymus, lymph node and testis. The imprints were
air-dried and stored at minus 15° C. Autopsy im-
prints were also studied. Bone marrow and buffy
coat peripheral blood smears were treated sim-
ilarly.
Staining and Examination
Specimens were incubated 30 minutes with
serum on a slowly rotatiDg shaker at 37° C.,
washed with saline and water, dried, and then
covered for 30 minutes with commercially avail-
able fluoresceiD conjugated goat antihuman
gamma globulin. § This had been diluted 1:5 with
buffered saline, pH 7.3, and extracted once with
ethyl acetate. Rhodamine labelled bovine serum
albumin, 0.05 cc in 2 cc of the diluted conjugate,
was used as a counterstain. The stained slides were
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examined with a Leitz Ortholux microscope using
an Osram L2 lamp, a BC 12 excitation filter and a
pale yellow barrier filter (Leitz). Known negative
and positive control sera were used with every
procedure.
RESULTS
Specific nuclear fluorescence was bright yellow-
green while cytoplasm stained orange with the
rhodamine.
TABLE I
Nuclear speckles and tumor imprints
Tumors Size ot Speckles
Seminoma +++
Leiomyosarcoma +++
Choriocarcinoma + + +
Rhabdomyosarcoma
Carcinoma of breast (2 differ-
ent tumors) +++
Papilloma of choroid plexus... +
Oligodendroglioma
Carcinoma of lung +++
Osteogenic sarcoma
Melanoma + +
Hodgkins disease (2 different
tumors (1) and (2)) (1) + (2) ---j---
+ = Size of speckles in lymphocytes and
other normal tissues.
= About 4 1< size of speckles in lym-
phocytes and other normal tissues.
Skin
Several scleroderma scm showed predominantly
Duclear, bright yellow-green fluorescent speckles
in the cells of the epidermis and hair follicles of
involved and normal skin (Fig. 1). Cytoplasmic
location of certain speckles was thought to be
caused by nuclear material displaced when the
sections were cot. Nucleolar fluorescence of epi-
dermal cells of involved and normal skin was seen
with one scleroderma serum.
Several of the L. E. cell positive sera produced
homogeneous nuclear fluorescence in normal epi-
dermis and hair follicles.
Otker Tissues
Speckled nuclear fluorescence was seen in all
the specimens (Figs. 2, 3, 4). The nuclear speckles
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Fin. 1. Normal skin incubated with scieroderma serum. Arrow shows one of the nuclear speckles.
FIG. 2. Buffy coat peripheral blood smear incubated with scleroderma serum. A. nonspecific fluores-
cent cytoplasmic granules of polymorphonuclear leukocyte, also present when normal serum was used.
B. small faint nuclear speckles.
Fin. 3. Leiomyosarcoma imprint incubated with scleroderma serum. Many bright large nuclear
speckles are seen. Compare with the small faint speckles in Figure 2.
Fin. 4. Hhabdomyosarcoma imprint incubated with scleroderma serum. Arrow shows one of the bright
large nuclear speckles. Compare with the small faint speckles in Fig. 2.
All photos were taken using 95 X Fluorite objective 10 X ocular, Leica MI body.
were brighter, more numerous and usually larger
in the tumor imprints than in the other specimens
(see Table I). Certain cells in the bone marrow
smears, lymph node imprints and spleen sections
also had larger speckles.
The tumor sections, although showing the same
type of speckles, were not as good as the imprints
due to nonspecific stromal fluorescence and poor
cell delineation.
Nucleolar fluorescence as described by Beck (3,
4) was also much more conspicuous in the tumor
imprints, with again brighter, larger and more
numerous nucleoli.
Homogeneous and membranous nuclear fluores-
cence (Beck (4) were demonstrated much better
in tumor, spleen and lymph node imprints than
in blood smears or tissue sections due to the
greater number, delineation and size (in tumor
imprints only) of the nuclei.
Controls
No specific yellow-green nuclear fluorescence
was seen in the control sera stained specimens.
EXPERIMENTAL VARIABLES
Tumor imprints were stored at 15° C. for up
to 4j/ months without loss of nuclear fluorescence
potential. A group of imprints stored at room
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temperature for five months failed to demonstrate
nuclear fluorescence potential.
No loss of nuclear fluorescence potential oc-
curred when tumors were stored for up to 96 hours
at 4—7° C. prior to being imprinted.
Autopsy material imprints also demonstrated
good nuclear fluorescence.
DIscussIoN
Tumor nuclei apparently contain more "speck-
led" and "nucleolar" antigens than normal nu-
clei, and therefore demonstrate these types of
fluorescence more conspicuously. Homogeneous
and membranous nuclear fluorescence are also seen
much more readily in tumor and some tissue im-
prints than in blood smears or tissue sections due
to the greater number, delineation and size of the
nuclei. Imprints lack the nonspecific stromal
fluorescence of sections and consequently have
superior nuclear definition. Many slides can be
prepared rapidly and stored for at least 4jz
months. Tumor imprints are thus an ideal nuclear
substrate for the detection of antinuclear factors.
5UMMARY
Sera of patients with positive lupus erythemato-
sus cell tests, scleroderma and various dermatoses
were investigated for antibodies to skin com-
ponents and antinuclear factors by the indirect
fluorescent antibody techaic.
Speckled nuclear fluorescence in the epidermis
was seen with several of the scleroderma sera.
Epidermal nucleolar fluorescence occurred with
one scleroderma serum, while homogeneous epi-
dermal nuclear fluorescence was seen with several
of the lupus erythematosus cell positive sera.
Tumor imprints were far superior for the de-
tection of antinuclear factors to the conventional
blood smears and tissue sections. Nuclear fluores-
cence was much more conspicuous due to the
greater number, size and delineation of nuclei and
to the greater quantity of some of the nuclear
antigens. We therefore suggest the routine use of
tumor imprints as a rapid and practical screening
test for antinuclear factors.
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